Tofurky, a processor of plant-analog proteins, will collaborate with Triton Algae Innovations to develop products incorporating protein from “essential red” algae.
Jaime Athos, CEO of Tofurky, said that the opportunity for the companies to combine their knowledge and understanding of the plant-based market with the nutrition and natural supply-chain technology created by Triton’s algae is unique and timely.
The process involves the selection and cultivation of algae strains that are rich in protein, omega-3 fatty acids, and other beneficial nutrients.
The products would be rolled out in the first quarter of next year, although the company's announcement did not furnish any descriptions or other specifics.
Athos noted that while they can’t share just yet what the products are, it would resonate with their core audience and be attractive to the rapidly growing flexitarian segment who are increasingly drawn to plant-based foods.


Asia Manufacturing PMI Rebounds as Exports and Tech Demand Drive Growth into 2026
Oil Prices Slide in 2025 as Oversupply and Geopolitical Risks Shape Market Outlook
Japanese Business Leaders Urge Government Action as Weak Yen Strains Economy
South Korea Inflation Rises to 2.3% in December, Matching Market Expectations
Trump Delays Tariff Increases on Furniture and Cabinets for One More Year
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
U.S. Dollar Steadies Ahead of Fed Minutes as Markets Eye Policy Divisions
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
South Korea Factory Output Misses Forecasts in November Amid Ongoing Economic Uncertainty
USDA $12 Billion Farm Aid Program Draws Mixed Reactions from Row Crop Farmers
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Asian Currencies Trade Flat as Dollar Weakens in Thin New Year Trading
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Federal Reserve Begins Treasury Bill Purchases to Stabilize Reserves and Money Markets
U.S. Dollar Starts 2026 Weak as Yen, Euro and Sterling Hold Firm Amid Rate Cut Expectations 



